[go: up one dir, main page]

DK0639179T3 - 23-oxaderivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemidler - Google Patents

23-oxaderivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemidler

Info

Publication number
DK0639179T3
DK0639179T3 DK92903336.3T DK92903336T DK0639179T3 DK 0639179 T3 DK0639179 T3 DK 0639179T3 DK 92903336 T DK92903336 T DK 92903336T DK 0639179 T3 DK0639179 T3 DK 0639179T3
Authority
DK
Denmark
Prior art keywords
derivatives
pct
vitamin
series
drugs
Prior art date
Application number
DK92903336.3T
Other languages
English (en)
Inventor
Martin Haberey
Petra Rach
Ruth Thieroff-Ekerdt
Guenter Neef
Katica Schwarz
Andreas Steinmeyer
Gerald Kirsch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0639179T3 publication Critical patent/DK0639179T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92903336.3T 1991-01-19 1992-01-20 23-oxaderivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemidler DK0639179T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4101953A DE4101953A1 (de) 1991-01-19 1991-01-19 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DK0639179T3 true DK0639179T3 (da) 1996-10-14

Family

ID=6423566

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92903336.3T DK0639179T3 (da) 1991-01-19 1992-01-20 23-oxaderivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemidler

Country Status (11)

Country Link
US (1) US5411949A (da)
EP (1) EP0639179B1 (da)
JP (1) JP3207423B2 (da)
AT (1) ATE138647T1 (da)
DE (2) DE4101953A1 (da)
DK (1) DK0639179T3 (da)
ES (1) ES2089497T3 (da)
GR (1) GR3020083T3 (da)
IE (1) IE74251B1 (da)
PT (1) PT100035B (da)
WO (1) WO1992012963A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2144013T3 (es) * 1992-10-16 2000-06-01 Chugai Pharmaceutical Co Ltd Derivado de la vitamina d y procedimiento para su produccion.
TW267161B (da) * 1992-11-20 1996-01-01 Hoffmann La Roche
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
WO1997024127A1 (en) * 1995-12-29 1997-07-10 A And D Assay, Incorporated Labeled vitamin d compounds and the use thereof
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) * 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
EP2340840B1 (en) 1998-03-27 2012-08-29 Oregon Health Sciences University Pulse dose Vitamin D drug for the treatment of hyperproliferative skin diseases
DK1178960T3 (da) 1999-04-23 2004-03-15 Leo Pharma As Vitamin D analoger og deres farmaceutiske anvendelse
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
AU2003292920A1 (en) * 2002-12-18 2004-07-09 Cytochroma Inc. 25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol)
BRPI0609630A2 (pt) 2005-05-10 2010-04-20 Dermipsor Ltd composições e métodos para tratamento de doenças epidérmicas hiperproliferativas
CA2661546A1 (en) 2006-08-25 2008-02-28 Cougar Biotechnology, Inc. Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
US20080051375A1 (en) * 2006-08-25 2008-02-28 Auerbach Alan H Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
US20080051380A1 (en) * 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
WO2009009132A1 (en) * 2007-07-12 2009-01-15 Cougar Biotechnology, Inc. Use of 17alpha-hydroxylase/c17, 20-lyase inhibitors for the treatment of cancer
CA2981549A1 (en) 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
AU2010282731C1 (en) 2009-08-14 2016-04-21 Berg Llc Vitamin D3 and analogs thereof for treating alopecia
FI124171B (en) 2012-05-29 2014-04-15 Matti Mällinen Biofilter
WO2017209934A1 (en) 2016-05-13 2017-12-07 Case Western Reserve University Autophagy activators for treating or preventing skin injury
WO2018023017A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of treating prostate cancer
US11903952B2 (en) 2020-05-27 2024-02-20 Northwestern University Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2114570B (en) * 1981-11-02 1985-08-07 Res Inst Medicine Chem Chemical compounds
CA1332841C (en) * 1984-11-27 1994-11-01 Noboru Kubodera Vitamin d derivatives and process for producing the same
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
IE74251B1 (en) 1997-07-16
EP0639179B1 (de) 1996-05-29
JPH06506915A (ja) 1994-08-04
ATE138647T1 (de) 1996-06-15
US5411949A (en) 1995-05-02
DE4101953A1 (de) 1992-07-23
IE920156A1 (en) 1992-07-29
ES2089497T3 (es) 1996-10-01
DE59206439D1 (de) 1996-07-04
EP0639179A4 (de) 1993-09-17
WO1992012963A1 (de) 1992-08-06
GR3020083T3 (en) 1996-08-31
JP3207423B2 (ja) 2001-09-10
EP0639179A1 (de) 1995-02-22
PT100035B (pt) 1999-08-31
PT100035A (pt) 1993-05-31

Similar Documents

Publication Publication Date Title
DK0639179T3 (da) 23-oxaderivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemidler
NO981944L (no) Lipopolyaminer som transfeksjonsmidler samt farmas÷ytisk anvendelse derav
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
ES2114931T3 (es) Nuevos esteres esteroidales.
FI922806A0 (fi) Substituerade 4-fenyl-4 -piperidinkarboxamider med baode lokalbedoevande och smaertstillande effekt samt foerfaranden foer deras framstaellning.
AU2960789A (en) Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AR024390A1 (es) Nuevos compuestos
ATE29255T1 (de) Succinimid-derivate und deren herstellung.
DK0421561T3 (da) 24-homo-vitamin-D-derivater, fremgangsmåder til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt deres anvendelse som lægemiddel
ES2051753T3 (es) N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
YU92192A (sr) Postupak za dobijanje preparata soli lipofilnih oligosaharidnih antibiotika
ES8403494A1 (es) "un procedimiento para la preparacion de derivados de s-adenosilmetionina".
DK0474712T3 (da) Anvendelse af lysolecitinderivater til fremstilling af et farmaceutisk præparat
ES2063039T3 (es) Derivados de imidazo(1,2-b)piridazina.
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
ATE138380T1 (de) Bicyclische pyrimidinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate
GR3023437T3 (en) 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs.
DE3686979D1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
DE69426908D1 (de) Derivate der Phosphonsäure, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen die sie enthalten
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
DE59104469D1 (de) Dialkoxybenzylidenkampfer-Derivate.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
DE3870167D1 (de) N-(vinblastinoyl-23)-derivate von 1-aminomethylposphonsaeure, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
AR012601A1 (es) Derivados de amidina, formulaciones farmaceuticas que los contiene, uso de dichos derivados en la preparacion de medicamentos y proceso para lapreparacion de dichos derivados
DK601888D0 (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater